Atlas FDA

GORE CARDIOFORM Septal Occluder

FDA premarket approval P050006/S085 · decided 2020-10-23

Approval details

PMA number
P050006
Supplement
S085
Supplement type
Normal 180 Day Track No User Fee
Supplement reason
Postapproval Study Protocol
Trade name
GORE CARDIOFORM Septal Occluder
Generic name
Transcatheter septal occluder
Applicant
W. L. Gore & Associates, Inc.
Date received
2020-07-27
Decision date
2020-10-23
Days to decision
88 days
Decision code
APPR
Product code
MLV
Advisory committee
Cardiovascular
Expedited review
No
Location
Phonix, AZ
Statement
Approval of the revised protocol, and subsequent revised version of the protocol for the post-approval study (PAS) protocol.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
GORE® Tri-Lobe Balloon Catheter (K250410)W. L. Gore & Associates, Inc.2025-06-02
GORE® PROPATEN® Vascular Graft (K240083)W. L. Gore & Associates, Inc.2024-03-01
GORE® PROPATEN® Vascular Graft (K232312)W. L. Gore & Associates, Inc.2024-01-09
GORE® ACUSEAL Vascular Graft (K233551)W. L. Gore & Associates, Inc.2023-12-19
GORE® ACUSEAL Vascular Graft (K231505)W. L. Gore & Associates, Inc.2023-06-23
GORE BIO-A Tissue Reinforcement (K191773)W. L. Gore & Associates, Inc.2019-07-31
GORE SEAMGUARD Bioabsorbable Staple Line Reinforcement (K181940)W. L. Gore & Associates, Inc.2018-08-17
GORE ENFORM Biomaterial (K173333)W. L. Gore & Associates, Inc.2018-04-05